Literature DB >> 21200168

Platelet-enriched plasma and muscle strain injuries: challenges imposed by the burden of proof.

Bruce H Hamilton1, Thomas M Best.   

Abstract

OBJECTIVE: To review the evidence for the clinical utilization of autologous plasma products in the management of muscle strain injuries.
METHOD: Systematic review using EMBASE and MEDLINE (up to March 2010).
RESULTS: There is no level 1, 2, and 3 evidence for the use of autologous plasma products in muscle strain injuries. Furthermore, significant methodological limitations impact on the interpretation of the few published studies in this field.
CONCLUSIONS: Although basic science and the use of recombinant growth factors in animal models support the concept of applying growth factors to acute muscle injuries, it is unclear if this evidence can be directly translated to reflect outcomes from platelet-enriched plasma. There remain a large number of unanswered questions, including the principle questions regarding safety and efficacy, which require appropriate scientific investigation. It is incumbent on sports physicians wishing to enhance athlete care, together with researchers, to search for these answers.

Entities:  

Mesh:

Year:  2011        PMID: 21200168     DOI: 10.1097/JSM.0b013e318205a658

Source DB:  PubMed          Journal:  Clin J Sport Med        ISSN: 1050-642X            Impact factor:   3.638


  15 in total

1.  The role of platelet-rich plasma in inducing musculoskeletal tissue healing.

Authors:  Brian C Halpern; Salma Chaudhury; Scott A Rodeo
Journal:  HSS J       Date:  2012-01-18

Review 2.  The use of platelet-rich plasma to augment conservative and surgical treatment of hip and pelvic disorders.

Authors:  Matthew J Kraeutler; Tigran Garabekyan; Omer Mei-Dan
Journal:  Muscles Ligaments Tendons J       Date:  2016-12-21

3.  Does platelet-rich plasma decrease time to return to sports in acute muscle tear? A randomized controlled trial.

Authors:  Luciano Andrés Rossi; Agustín Rubén Molina Rómoli; Bernardo Agustín Bertona Altieri; Jose Aurelio Burgos Flor; Walter Edgardo Scordo; Cristina María Elizondo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-16       Impact factor: 4.342

4.  Analysis of photobiomodulation associated or not with platelet-rich plasma on repair of muscle tissue by Raman spectroscopy.

Authors:  Guilherme Akio Tamura Ozaki; Regina Celi Trindade Camargo; Tatiana Emy Koike; Thiago Alves Garcia; Robson Chacon Castoldi; João Domingos Augusto Dos Santos Pereira; Carlos José Leopoldo Constantino; José Carlos Silva Camargo Filho
Journal:  Lasers Med Sci       Date:  2016-09-20       Impact factor: 3.161

Review 5.  Regeneration of Skeletal Muscle After Eccentric Injury.

Authors:  Jeffrey J Dueweke; Tariq M Awan; Christopher L Mendias
Journal:  J Sport Rehabil       Date:  2016-12-19       Impact factor: 1.931

Review 6.  Availability of platelet-rich plasma for treatment of erectile dysfunction and associated costs and efficacy: A review of current publications and Canadian data.

Authors:  Deron Britt; Udi Blankstein; Matthew Lenardis; Alexandra Millman; Ethan Grober; Yonah Krakowsky
Journal:  Can Urol Assoc J       Date:  2021-06       Impact factor: 1.862

Review 7.  Myotoxicity of injections for acute muscle injuries: a systematic review.

Authors:  Gustaaf Reurink; Gert Jan Goudswaard; Maarten H Moen; Adam Weir; Jan A N Verhaar; Johannes L Tol
Journal:  Sports Med       Date:  2014-07       Impact factor: 11.136

8.  Hamstring muscle strain injuries: what can we learn from history?

Authors:  Bruce Hamilton
Journal:  Br J Sports Med       Date:  2012-03-29       Impact factor: 13.800

Review 9.  Tissue engineered strategies for skeletal muscle injury.

Authors:  Umile Giuseppe Longo; Mattia Loppini; Alessandra Berton; Filippo Spiezia; Nicola Maffulli; Vincenzo Denaro
Journal:  Stem Cells Int       Date:  2011-11-10       Impact factor: 5.443

Review 10.  Platelet-rich plasma (PRP) for acute muscle injury: a systematic review.

Authors:  Mohamad Shariff A Hamid; Ashril Yusof; Mohamed Razif Mohamed Ali
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.